{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:21Z","timestamp":1787020941011,"version":"build-2736575974"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08065, 19K08413, 20K08370, 17H04169"],"award-info":[{"award-number":["22K08065, 19K08413, 20K08370, 17H04169"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08065, 19K08413, 20K08370, 17H04169"],"award-info":[{"award-number":["22K08065, 19K08413, 20K08370, 17H04169"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08065, 19K08413, 20K08370, 17H04169"],"award-info":[{"award-number":["22K08065, 19K08413, 20K08370, 17H04169"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19km0405205h9904"],"award-info":[{"award-number":["19km0405205h9904"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19km0405205h9904"],"award-info":[{"award-number":["19km0405205h9904"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NHO"},{"name":"Ministry of Health, Labour, and Welfare of Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Ligation of CD28 with ligands such as CD80 or CD86 provides a critical second signal alongside antigen presentation by class II major histocompatibility complex expressed on antigen-presenting cells through the T cell antigen receptor for na\u00efve T cell activation. A number of studies suggested that CD28 plays an important role in the pathogenesis of various human diseases. Recent genome-wide association studies (GWASs) identified\n                      <jats:italic>CD28<\/jats:italic>\n                      as a susceptibility locus for lymphocyte and eosinophil counts, multiple sclerosis, ulcerative colitis, celiac disease, rheumatoid arthritis, asthma, and primary biliary cholangitis. However, the primary functional variant and molecular mechanisms of disease susceptibility in this locus remain to be elucidated. This study aimed to identify the primary functional variant from thousands of genetic variants in the\n                      <jats:italic>CD28<\/jats:italic>\n                      locus and elucidate its functional effect on the CD28 molecule.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the genetic variants exhibiting stronger linkage disequilibrium (LD) with all GWAS-lead variants in the\n                      <jats:italic>CD28<\/jats:italic>\n                      locus, rs2013278, located in the Rbfox binding motif related to splicing regulation, was identified as a primary functional variant related to multiple immunological traits. Relative endogenous expression levels of\n                      <jats:italic>CD28<\/jats:italic>\n                      splicing isoforms (CD28i and CD28\u0394ex2) compared with full-length CD28 in allele knock-in cell lines generated using CRISPR\/Cas9 were directly regulated by rs2013278 (P\u2009&lt;\u20090.05). Although full-length CD28 protein expressed on Jurkat T cells showed higher binding affinity for CD80\/CD86, both CD28i and CD28\u0394ex2 encoded loss-of-function isoforms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The present study demonstrated for the first time that\n                      <jats:italic>CD28<\/jats:italic>\n                      has a shared disease-related primary functional variant (i.e., rs2013278) that regulates the CD28 alternative splicing that generates loss-of-function isoforms. They reduce disease risk by inducing anergy of effector T cells that over-react to autoantigens and allergens.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40246-022-00419-7","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T05:02:37Z","timestamp":1666328557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["rs2013278 in the multiple immunological-trait susceptibility locus CD28 regulates the production of non-functional splicing isoforms"],"prefix":"10.1186","volume":"16","author":[{"given":"Yuki","family":"Hitomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minae","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Tsuiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Iwabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanami","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushi","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"419_CR1","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.4049\/jimmunol.153.5.1990","volume":"153","author":"DJ Lenschow","year":"1994","unstructured":"Lenschow DJ, Sperling AI, Cooke MP, Freeman G, Rhee L, Decker DC, et al. Differential up-regulation of the B7\u20131 and B7\u20132 costimulatory molecules after Ig receptor engagement by antigen. J Immunol. 1994;153:1990\u20137.","journal-title":"J Immunol"},{"key":"419_CR2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","volume":"4","author":"JH Esensten","year":"2016","unstructured":"Esensten JH, Helou YA, Chopra G, Weiss A, Bluestone JA. CD28 costimulation: from mechanism to therapy. Immunity. 2016;4:973\u201388.","journal-title":"Immunity"},{"key":"419_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1126\/science.1846244","volume":"251","author":"JD Fraser","year":"1991","unstructured":"Fraser JD, Irving BA, Crabtree GR, Weiss A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science. 1991;251:313\u20136.","journal-title":"Science"},{"key":"419_CR4","first-page":"4472","volume":"7","author":"CH June","year":"1987","unstructured":"June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol. 1987;7:4472\u201381.","journal-title":"Mol Cell Biol"},{"key":"419_CR5","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1073\/pnas.86.4.1333","volume":"86","author":"CB Thompson","year":"1989","unstructured":"Thompson CB, Lindsten T, Ledbetter JA, Kunkel SL, Young HA, Emerson SG, et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines\/cytokines. Proc Natl Acad Sci USA. 1989;86:1333\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"419_CR6","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1073\/pnas.87.13.5031","volume":"87","author":"PS Linsley","year":"1990","unstructured":"Linsley PS, Clark EA, Ledbetter JA. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7\/BB-1. Proc Natl Acad Sci USA. 1990;87:5031\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"419_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.182.2.459","volume":"182","author":"MF Krummel","year":"1995","unstructured":"Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med. 1995;182:459\u201365.","journal-title":"J Exp Med"},{"key":"419_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/1074-7613(94)90071-X","volume":"1","author":"TL Walunas","year":"1994","unstructured":"Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1994;1:405\u201313.","journal-title":"Immunity"},{"key":"419_CR9","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.4049\/jimmunol.177.2.1052","volume":"177","author":"JJ Engelhardt","year":"2006","unstructured":"Engelhardt JJ, Sullivan TJ, Allison JP. CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism. J Immunol. 2006;177:1052\u201361.","journal-title":"J Immunol"},{"key":"419_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1126\/science.7688139","volume":"261","author":"A Shahinian","year":"1993","unstructured":"Shahinian A, Pfeffer K, Lee KP, K\u00fcndig TM, Kishihara K, Wakeham A, et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science. 1993;261:609\u201312.","journal-title":"Science"},{"key":"419_CR11","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.4049\/jimmunol.156.12.4576","volume":"156","author":"SE Ferguson","year":"1996","unstructured":"Ferguson SE, Han S, Kelsoe G, Thompson CB. CD28 is required for germinal center formation. J Immunol. 1996;156:4576\u201381.","journal-title":"J Immunol"},{"key":"419_CR12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4049\/jimmunol.163.3.1128","volume":"163","author":"MF Bachmann","year":"1999","unstructured":"Bachmann MF, Kohler G, Ecabert B, Mak TW, Kopf M. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J Immunol. 1999;163:1128\u201331.","journal-title":"J Immunol"},{"key":"419_CR13","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1126\/science.1255904","volume":"345","author":"HS Kuehn","year":"2014","unstructured":"Kuehn HS, Ouyang W, Lo B, Deenick EK, Niemela JE, Avery DT, et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science. 2014;345:1623\u20137.","journal-title":"Science"},{"key":"419_CR14","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.3746","volume":"20","author":"D Schubert","year":"2014","unstructured":"Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med. 2014;20:1410\u20136.","journal-title":"Nat Med"},{"key":"419_CR15","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","volume":"142","author":"C Schwab","year":"2018","unstructured":"Schwab C, Gabrysch A, Olbrich P, Pati\u00f1o V, Warnatz K, Wolff D, et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. J Allergy Clin Immunol. 2018;142:1932\u201346.","journal-title":"J Allergy Clin Immunol"},{"key":"419_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000242355","volume":"151","author":"V Lombardi","year":"2010","unstructured":"Lombardi V, Singh AK, Akbari O. The role of costimulatory molecules in allergic disease and asthma. Int Arch Allergy Immunol. 2010;151:179\u201389.","journal-title":"Int Arch Allergy Immunol"},{"key":"419_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/(SICI)1096-9896(1998100)186:2<126::AID-PATH167>3.0.CO;2-1","volume":"186","author":"K Tsuneyama","year":"1998","unstructured":"Tsuneyama K, Harada K, Yasoshima M, Kaji K, Gershwin ME, Nakanuma Y. Expression of co-stimulatory factor B7\u20132 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study. J Pathol. 1998;186:126\u201330.","journal-title":"J Pathol"},{"key":"419_CR18","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.cell.2020.06.045","volume":"182","author":"MH Chen","year":"2020","unstructured":"Chen MH, Raffield LM, Mousas A, Sakaue S, Huffman JE, Moscati A, et al. Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations. Cell. 2020;182:1198\u2013213.","journal-title":"Cell"},{"key":"419_CR19","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.cell.2020.08.008","volume":"182","author":"D Vuckovic","year":"2020","unstructured":"Vuckovic D, Bao EL, Akbari P, Lareau CA, Mousas A, Jiang T, et al. The polygenic and monogenic basis of blood traits and diseases. Cell. 2020;182:1214\u201331.","journal-title":"Cell"},{"key":"419_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajhg.2018.11.008","volume":"104","author":"G Kichaev","year":"2019","unstructured":"Kichaev G, Bhatia G, Loh PR, Gazal S, Burch K, Freund MK, et al. Leveraging polygenic functional enrichment to improve GWAS power. Am J Hum Genet. 2019;104:65\u201375.","journal-title":"Am J Hum Genet"},{"key":"419_CR21","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ng.2770","volume":"45","author":"AH Beecham","year":"2013","unstructured":"International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013;45:1353\u201360.","journal-title":"Nat Genet"},{"key":"419_CR22","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","volume":"47","author":"JZ Liu","year":"2015","unstructured":"Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47:979\u201386.","journal-title":"Nat Genet"},{"key":"419_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ejhg.2015.87","volume":"24","author":"C Coleman","year":"2016","unstructured":"Coleman C, Quinn EM, Ryan AW, Conroy J, Trimble V, Mahmud N, et al. Common polygenic variation in coeliac disease and confirmation of ZNF335 and NIFA as disease susceptibility loci. Eur J Hum Genet. 2016;24:291\u20137.","journal-title":"Eur J Hum Genet"},{"key":"419_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/hmg\/ddv455","volume":"25","author":"J Gutierrez-Achury","year":"2016","unstructured":"Gutierrez-Achury J, Zorro MM, Rica\u00f1o-Ponce I, Zhernakova DV, Coeliac Disease Immunochip Consortium, RACI Consortium, Diogo D, et al. Functional implications of disease-specific variants in loci jointly associated with coeliac disease and rheumatoid arthritis. Hum Mol Genet. 2016;25:180\u201390.","journal-title":"Hum Mol Genet"},{"key":"419_CR25","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.998","volume":"43","author":"G Trynka","year":"2011","unstructured":"Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, Szperl A, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet. 2011;43:1193\u2013201.","journal-title":"Nat Genet"},{"key":"419_CR26","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014;506:376\u201381.","journal-title":"Nature"},{"key":"419_CR27","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/hmg\/ddy395","volume":"28","author":"VA Laufer","year":"2019","unstructured":"Laufer VA, Tiwari HK, Reynolds RJ, Danila MI, Wang J, Edberg JC, et al. Genetic influences on susceptibility to rheumatoid arthritis in African-Americans. Hum Mol Genet. 2019;28:858\u201374.","journal-title":"Hum Mol Genet"},{"key":"419_CR28","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/ng.2462","volume":"44","author":"S Eyre","year":"2012","unstructured":"Eyre S, Bowes J, Diogo D, Lee A, Barton A, Martin P, et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet. 2012;44:1336\u201340.","journal-title":"Nat Genet"},{"key":"419_CR29","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue S, Kanai M, Tanigawa Y, Karjalainen J, Kurki M, Koshiba S, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53:1415\u201324.","journal-title":"Nat Genet"},{"key":"419_CR30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jhep.2021.04.055","volume":"75","author":"HJ Cordell","year":"2021","unstructured":"Cordell HJ, Fryett JJ, Ueno K, Darlay R, Aiba Y, Hitomi Y, et al. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs. J Hepatol. 2021;75:572\u201381.","journal-title":"J Hepatol"},{"key":"419_CR31","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1055\/s-0034-1383732","volume":"34","author":"M Nakamura","year":"2014","unstructured":"Nakamura M. Clinical significance of autoantibodies in primary biliary cirrhosis. Semin Liver Dis. 2014;34:334\u201340.","journal-title":"Semin Liver Dis"},{"key":"419_CR32","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1084\/jem.181.5.1835","volume":"181","author":"S Shimoda","year":"1995","unstructured":"Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y. HLA-DRB4* 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med. 1995;181:1835\u201345.","journal-title":"J Exp Med"},{"key":"419_CR33","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1172\/JCI4213","volume":"102","author":"S Shimoda","year":"1998","unstructured":"Shimoda S, Van de Water J, Ansari A, Nakamura M, Ishibashi H, Coppel RL, et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest. 1998;102:1831\u201340.","journal-title":"J Clin Invest"},{"key":"419_CR34","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261\u201373.","journal-title":"N Engl J Med"},{"key":"419_CR35","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","volume":"377","author":"C Selmi","year":"2011","unstructured":"Selmi C, Bowlus CL, Gershwin ME, Coppel RL. Primary biliary cirrhosis. Lancet. 2011;377:1600\u20139.","journal-title":"Lancet"},{"key":"419_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0168-8278(99)80097-X","volume":"30","author":"DE Jones","year":"1999","unstructured":"Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF. Familial primary biliary cholangitis reassessed: a geographically based population study. J Hepatol. 1999;30:402\u20137.","journal-title":"J Hepatol"},{"key":"419_CR37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","volume":"127","author":"C Selmi","year":"2004","unstructured":"Selmi C, Mayo MJ, Bach N, Ishibashi H, Invernizzi P, Gish RG, et al. Primary biliary cholangitis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology. 2004;127:485\u201392.","journal-title":"Gastroenterology"},{"key":"419_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/bbrc.1999.0725","volume":"259","author":"G Magistrelli","year":"1999","unstructured":"Magistrelli G, Jeannin P, Elson G, Gauchat JF, Nguyen TN, Bonnefoy JY, et al. Identification of three alternatively spliced variants of human CD28 mRNA. Biochem Biophys Res Commun. 1999;259:34\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"419_CR39","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1182\/blood.V99.6.2138","volume":"99","author":"H Hanawa","year":"2002","unstructured":"Hanawa H, Ma Y, Mikolajczak SA, Charles ML, Yoshida T, Yoshida R, et al. A novel costimulatory signaling in human T lymphocytes by a splice variant of CD28. Blood. 2002;99:2138\u201345.","journal-title":"Blood"},{"key":"419_CR40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cell.2016.03.040","volume":"165","author":"A Damianov","year":"2016","unstructured":"Damianov A, Ying Y, Lin CH, Lee JA, Tran D, Vashisht AA, et al. Rbfox proteins regulate splicing as part of a large multiprotein complex LASR. Cell. 2016;165:606\u201319.","journal-title":"Cell"},{"key":"419_CR41","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1093\/nar\/29.13.2850","volume":"29","author":"B Modrek","year":"2001","unstructured":"Modrek B, Resch A, Grasso C, Lee C. Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res. 2001;29:2850\u20139.","journal-title":"Nucleic Acids Res"},{"key":"419_CR42","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nri727","volume":"2","author":"AH Sharpe","year":"2002","unstructured":"Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol. 2002;2:116\u201326.","journal-title":"Nat Rev Immunol"},{"key":"419_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1074-7613(00)80333-7","volume":"6","author":"F Borriello","year":"1997","unstructured":"Borriello F, Sethna MP, Boyd SD, Schweitzer AN, Tivol EA, Jacoby D, et al. B7\u20131 and B7\u20132 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity. 1997;6:303\u201313.","journal-title":"Immunity"},{"key":"419_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.immunol.20.091101.091806","volume":"20","author":"BM Carreno","year":"2002","unstructured":"Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol. 2002;20:29\u201353.","journal-title":"Annu Rev Immunol"},{"key":"419_CR45","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/ni1170","volume":"6","author":"EJ Evans","year":"2005","unstructured":"Evans EJ, Esnouf RM, Manso-Sancho R, Gilbert RJ, James JR, Yu C, et al. Crystal structure of a soluble CD28-Fab complex. Nat Immunol. 2005;6:271\u20139.","journal-title":"Nat Immunol"},{"key":"419_CR46","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nsb0797-527","volume":"4","author":"WJ Metzler","year":"1997","unstructured":"Metzler WJ, Bajorath J, Fenderson W, Shaw SY, Constantine KL, Naemura J, et al. Solution structure of human CTLA-4 and delineation of a CD80\/CD86 binding site conserved in CD28. Nat Struct Biol. 1997;4:527\u201331.","journal-title":"Nat Struct Biol"},{"key":"419_CR47","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature01621","volume":"423","author":"H Ueda","year":"2003","unstructured":"Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003;423:506\u201311.","journal-title":"Nature"},{"key":"419_CR48","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1365-3083.2007.02009.x","volume":"66","author":"M Kakoulidou","year":"2007","unstructured":"Kakoulidou M, Giscombe R, Zhao X, Lefvert AK, Wang X. Human Soluble CD80 is generated by alternative splicing, and recombinant soluble CD80 binds to CD28 and CD152 influencing T-cell activation. Scant J Immunol. 2007;66:529\u201337.","journal-title":"Scant J Immunol"},{"key":"419_CR49","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.4049\/jimmunol.180.6.3815","volume":"180","author":"EK Kapsogeorgou","year":"2008","unstructured":"Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN. A novel B7\u20132 (CD86) splice variant with a putative negative regulatory role. J Immunol. 2008;180:3815\u201323.","journal-title":"J Immunol"},{"key":"419_CR50","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","volume":"4","author":"M Uhl\u00e9n","year":"2005","unstructured":"Uhl\u00e9n M, Bj\u00f6rling E, Agaton C, Szigyarto CA, Amini B, Andersen E, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics. 2005;4:1920\u201332.","journal-title":"Mol Cell Proteomics"},{"key":"419_CR51","doi-asserted-by":"publisher","first-page":"eaal3321","DOI":"10.1126\/science.aal3321","volume":"356","author":"PJ Thul","year":"2017","unstructured":"Thul PJ, \u00c5kesson L, Wiking M, Mahdessian D, Geladaki A, AitBlal H, et al. A subcellular map of the human proteome. Science. 2017;356:eaal3321.","journal-title":"Science"},{"key":"419_CR52","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00439-015-1556-3","volume":"134","author":"Y Hitomi","year":"2015","unstructured":"Hitomi Y, Kawashima M, Aiba Y, Nishida N, Matsuhashi M, Okazaki H, et al. Human primary biliary cirrhosis-susceptible allele of rs4979462 enhances TNFSF15 expression by binding NF-1. Hum Genet. 2015;134:737\u201347.","journal-title":"Hum Genet"},{"key":"419_CR53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41598-018-36490-1","volume":"9","author":"Y Hitomi","year":"2019","unstructured":"Hitomi Y, Ueno K, Kawai Y, Nishida N, Kojima K, Kawashima M, et al. POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33. Sci Rep. 2019;9:102.","journal-title":"Sci Rep"},{"key":"419_CR54","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1038\/s41598-017-03067-3","volume":"7","author":"Y Hitomi","year":"2017","unstructured":"Hitomi Y, Kojima K, Kawashima M, Kawai Y, Nishida N, Aiba Y, et al. Identification of the functional variant driving ORMDL3 and GSDMB expression in human chromosome 17q12-21 in primary biliary cholangitis. Sci Rep. 2017;7:2904.","journal-title":"Sci Rep"},{"key":"419_CR55","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jcmgh.2018.11.006","volume":"7","author":"Y Hitomi","year":"2019","unstructured":"Hitomi Y, Nakatani K, Kojima K, Nishida N, Kawai Y, Kawashima M, et al. NFKB1 and MANBA confer disease susceptibility to primary biliary cholangitis via independent putative primary functional variants. Cell Mol Gastroenterol Hepatol. 2019;7:515\u201332.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"419_CR56","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1038\/s41598-021-84042-x","volume":"11","author":"Y Hitomi","year":"2021","unstructured":"Hitomi Y, Aiba Y, Kawai Y, Kojima K, Ueno K, Nishida N, et al. rs1944919 on chromosome 11q23.1 and its effector genes COLCA1\/COLCA2 confer susceptibility to primary biliary cholangitis. Sci Rep. 2021;11:4557.","journal-title":"Sci Rep"},{"key":"419_CR57","doi-asserted-by":"publisher","first-page":"102775","DOI":"10.1016\/j.jaut.2021.102775","volume":"126","author":"Y Hitomi","year":"2022","unstructured":"Hitomi Y, Aiba Y, Ueno K, Nishida N, Kawai Y, Kawashima M, et al. rs9459874 and rs1012656 in CCR6\/FGFR1OP confer susceptibility to primary biliary cholangitis. J Autoimmun. 2022;126:102775.","journal-title":"J Autoimmun"},{"key":"419_CR58","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/s41431-021-00854-5","volume":"29","author":"O Gervais","year":"2021","unstructured":"Gervais O, Ueno K, Kawai Y, Hitomi Y, Aiba Y, Ueta M, et al. Regional heritability mapping identifies several novel loci (STAT4, ULK4, and KCNH5) for primary biliary cholangitis in the Japanese population. Eur J Hum Genet. 2021;29:1282\u201391.","journal-title":"Eur J Hum Genet"},{"key":"419_CR59","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12864-018-4718-6","volume":"19","author":"L Gioia","year":"2018","unstructured":"Gioia L, Siddique A, Head SR, Salomon DR, Su AI. A genome-wide survey of mutations in the Jurkat cell line. BMC Genomics. 2018;19:334.","journal-title":"BMC Genomics"},{"key":"419_CR60","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jmedgenet-2012-100819","volume":"49","author":"AC Need","year":"2012","unstructured":"Need AC, Shashi V, Hitomi Y, Schoch K, Shianna KV, McDonald MT, et al. Clinical application of exome sequencing in undiagnosed genetic conditions. J Med Genet. 2012;49:353\u201361.","journal-title":"J Med Genet"},{"key":"419_CR61","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1093\/hmg\/ddh318","volume":"13","author":"Y Hitomi","year":"2004","unstructured":"Hitomi Y, Tsuchiya N, Kawasaki A, Ohashi J, Suzuki T, Kyogoku C, et al. CD72 polymorphisms associated with alternative splicing modify susceptibility to human systemic lupus erythematosus through epistatic interaction with FCGR2B. Hum Mol Genet. 2004;13:2907\u201317.","journal-title":"Hum Mol Genet"},{"key":"419_CR62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2172-13-72","volume":"13","author":"Y Hitomi","year":"2012","unstructured":"Hitomi Y, Adachi T, Tsuchiya N, Honda Z, Tokunaga K, Tsubata T. Human CD72 splicing isoform responsible for resistance to systemic lupus erythematosus regulates serum immunoglobulin level and is localized in endoplasmic reticulum. BMC Immunol. 2012;13:72.","journal-title":"BMC Immunol"},{"key":"419_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107612","volume":"96","author":"M Liu","year":"2021","unstructured":"Liu M, Yu Y, Hu S. A review on applications of abatacept in systemic rheumatic diseases. Int Immunopharmacol. 2021;96: 107612.","journal-title":"Int Immunopharmacol"},{"key":"419_CR64","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/471561a","volume":"471","author":"H Ledford","year":"2011","unstructured":"Ledford H. Melanoma drug wins US approval. Nature. 2011;471:561.","journal-title":"Nature"},{"key":"419_CR65","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa063842","volume":"355","author":"G Suntharalingam","year":"2006","unstructured":"Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, et al. Cytokine Storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med. 2006;355:1018\u201328.","journal-title":"N Engl J Med"},{"key":"419_CR66","first-page":"45","volume":"34","author":"D Tyrsin","year":"2016","unstructured":"Tyrsin D, Chuvpilo S, Matskevich A, Nemenov D, R\u00f6mer PS, Tabares P, et al. From TGN1412 to TAB08: the return of CD28 superagonist therapy to clinical development for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2016;34:45\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"419_CR67","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res. 2002;12:996\u20131006.","journal-title":"Genome Res"},{"key":"419_CR68","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","volume":"31","author":"MJ Machiela","year":"2015","unstructured":"Machiela MJ, Chanock SJ. LDlink a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 2015;31:3555\u20137.","journal-title":"Bioinformatics"},{"key":"419_CR69","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GTEx Consortium","year":"2013","unstructured":"GTEx Consortium. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45:580\u20135.","journal-title":"Nat Genet"},{"key":"419_CR70","doi-asserted-by":"publisher","first-page":"e0161879","DOI":"10.1371\/journal.pone.0161879","volume":"11","author":"S Basu","year":"2016","unstructured":"Basu S, Wallner B. DockQ: a quality measure for protein-protein docking models. PLoS ONE. 2016;11:e0161879.","journal-title":"PLoS ONE"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-022-00419-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-022-00419-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-022-00419-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T06:27:32Z","timestamp":1678343252000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-022-00419-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["419"],"URL":"https:\/\/doi.org\/10.1186\/s40246-022-00419-7","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"24 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no known competing economic interests or personal relationships that may affect the studies reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}